← Back to Clinical Trials
Recruiting NCT00697411

NCT00697411 Study of Selected X-Linked Disorders: Aicardi Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT00697411
Status Recruiting
Phase
Sponsor Baylor College of Medicine
Condition Aicardi Syndrome
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2002-10
Primary Completion 2030-01

Trial Parameters

Condition Aicardi Syndrome
Sponsor Baylor College of Medicine
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2002-10
Completion 2030-01
Interventions
Syndrome cause identification

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Based on our current understanding of Aicardi syndrome, the condition is hypothesized to occur due to a genetic change on the X-chromosome. The research team is investigating Aicardi syndrome to identify the specific gene location associated with the disorder. The investigators are collecting blood and skin biopsy samples from patients and their parents. A permanent cell line is prepared and DNA from the blood and skin samples and cell lines is isolated and then used for genetic testing. The current research includes microarray analysis which which is used to look for duplications or deletions of genetic material, mutation analysis of candidate genes by sequencing, genome-wide sequencing, review of medical records to identify trends suggesting possible candidate genes of interest, and X chromosome inactivation studies.

Eligibility Criteria

Inclusion Criteria: * Features suggestive of Aicardi syndrome (not all features must be present) * Agenesis of the corpus callosum * Chorioretinal lacunae * Seizures (infantile spasms) Exclusion Criteria: * none

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology